EEG in ADHD: The Beginning of a New Era?

Recent research offers new perspectives on the use of the electroencephalogram (EEG) for the diagnosis and treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). ADHD is a common neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity, affecting about 5% of children and 2.5% of adults worldwide (at least according to this study). Although diagnosis typically relies on clinical observations and standardized questionnaires, these methods remain subjective and can lead to inconsistencies. EEG, a non-invasive tool that measures the brain’s electrical activity, is attracting growing interest because of its diagnostic and therapeutic potential.

The main advantage of EEG lies in its ability to objectively capture brain activity, enabling clinicians to detect neurophysiological markers associated with ADHD. Recent advances have also highlighted the effectiveness of EEG-based neurofeedback, which aims to modify brain activity patterns to alleviate symptoms. This review examines how EEG contributes to ADHD diagnosis and evaluates the effectiveness of neurofeedback as a therapeutic intervention.

Methodology

A comprehensive review of recent studies explored the application of EEG in ADHD, using databases such as PubMed, PsycINFO, Scopus, and Web of Science. The analysis focused on articles published between 2000 and 2024 that presented empirical data on EEG for diagnosis and on the efficacy of neurofeedback interventions. In total, 58 studies meeting strict inclusion criteria were examined, split between those addressing diagnosis (32 studies) and those focused on therapy (26 studies).

Results

qEEG as a Diagnostic Tool

One of the most frequently reported findings in qEEG research on ADHD is an elevated theta/beta ratio, indicating a predominance of slower theta waves relative to faster beta waves. This pattern reflects deficits in sustained attention and cognitive control—hallmarks of ADHD. Monastra et al. (2001) first showed that this biomarker could distinguish ADHD patients from controls with 86% sensitivity and 98% specificity. Although many studies have replicated these results, their specificity remains debated because similar patterns are seen in conditions such as anxiety and sleep disorders.

The heterogeneous nature of ADHD further complicates EEG use. Research has shown that ADHD subtypes—such as the inattentive type and the hyperactive-impulsive type—display distinct EEG patterns. For example, individuals with the inattentive subtype often show a marked increase in theta activity, whereas those with the hyperactive-impulsive subtype may present excessive activity in the beta band. These differences underscore EEG’s potential to differentiate ADHD subtypes and enable more personalized treatment plans.

Neurofeedback for ADHD Treatment

Neurofeedback is an innovative approach that uses EEG to provide real-time visual or auditory feedback, helping individuals modulate their brain activity. (I honestly don't like ysing the word treatment; neurofeedback in this context is more like brain rehabilitation). Training most often aims to reduce theta activity while increasing beta activity, thereby promoting better attention and cognitive regulation. A meta-analysis by Arns et al. (2014) showed that neurofeedback significantly improves inattention and hyperactivity symptoms compared with placebo treatments or no treatment, yielding moderate-to-large effect sizes (d = 0.62). Other studies, such as Steiner et al. (2014), found that neurofeedback effectiveness was comparable to standard pharmacological treatments like methylphenidate.

However, variability in results across studies presents challenges. Treatment efficacy may vary with protocol specifics, such as the number of sessions (typically 20–40) and the targeted frequency bands. Moreover, in these studies the possibility that observed improvements are partly attributable to non-specific effects—owing to the novelty and technological appeal of neurofeedback—has not been well controlled, highlighting the need for stronger, better-controlled methodologies.

Brendan’s perspective

The role of EEG in ADHD diagnosis and intervention is promising, though complex. (Honestly, I don’t love the word “treatment” here; in this context, neurofeedback is better understood as a form of brain retraining.) While the theta/beta ratio is a compelling diagnostic indicator, overlap with other disorders underscores the need for multimodal approaches that combine qEEG with behavioral assessments or imaging to improve precision. Advanced technologies—such as wearable EEG devices and hybrid models integrating EEG and fMRI—could transform ADHD diagnosis by making it more accessible and precise.

While standardization is essential for consistency and broader clinical uptake, I would argue that it should not come at the expense of individualized treatment strategies. Individual neurophysiological differences mean that a one-size-fits-all approach could limit the effectiveness of neurofeedback interventions. Tailoring training to each person’s brainwave profile and symptom presentation can optimize outcomes. For instance, someone primarily showing increased theta activity may require a different training plan than another person with spindle-like beta features (beta spindles), while also allowing personalized definitions of the theta and beta bands.

I believe the balance between standardization and individualization is crucial for refining neurofeedback as a practical, effective modality. Personalization ensures that protocols remain adaptive, responsive to ADHD’s varied presentations, and supportive of targeted neurocognitive rehabilitation. Integrating standardized-yet-flexible protocols could bridge the gap between rigorous scientific methods and individualized patient needs, enabling clinicians to deliver care that is both evidence-based and patient-specific.

Integrative approaches that combine neurofeedback with traditional ADHD treatments—such as medication or cognitive-behavioral therapy—may offer comprehensive benefits. Future research should prioritize identifying the patient subtypes who respond best to EEG-based interventions and assessing the durability of neurofeedback effects over the long term through extended follow-up studies.

Conclusion

EEG has proven to be a valuable tool for the diagnosis and management of ADHD, providing objective insights into brain activity that can complement traditional clinical assessments. Although neurofeedback shows promise as a non-pharmacological intervention, the field must overcome issues of standardization and variability to strengthen its clinical viability. By adopting a balanced approach that respects the need for both standardization and individualization, EEG and neurofeedback can become powerful tools in addressing ADHD, fostering more precise, patient-centered care.

References

Altable, M., Díaz-Moreno, E., & Fulgheri, F. (2024). Electroencephalogram (EEG) in ADHD: A Comprehensive Systematic Review of Diagnostic and Therapeutic Applications. Preprints.org. https://doi.org/10.20944/preprints202410.2416.v1